Terapi hormon feminin: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
RXerself (bicara | kontrib)
gambar
RXerself (bicara | kontrib)
ref
 
Baris 3:
 
'''Terapi hormon feminin''' (''feminizing hormone theraphy''), atau disebut juga '''terapi hormon perempuan transgender''' (laki-laki ke perempuan, ''male-to-female'', MTF) adalah bentuk [[terapi hormon transgender|terapi penyulihan hormon]] [[transgender]] bagi [[Transpuan|wanita transgender]] dan orang [[transfeminin]] lainnya. Terapi ini bertujuan untuk mengurangi [[hormon]] dan [[karakteristik seks sekunder]] maskulin serta meningkatkan hormon dan karakteristik seks sekunder feminin seseorang sesuai dengen [[identitas gender]] orang tersebut.{{sfn|Hembree, et al.|2017|p=3885-3887}} Terdapat pula orang [[interseks]] yang memperoleh terapi ini, baik sejak kanak-kanak untuk mengkonfirmasi [[penunjukan seks|gendernya yang ditunjuk]] saat lahir atau saat remaja atau dewasa jika gender yang ditunjuk tersebut salah.
[[Berkas:Hormone levels with low-dose estradiol gel and oral cyproterone acetate in transgender women.png|jmpl|Perubahan tingkat estradiol (pg/mL), testosteron (ng/dL), dan [[Laktogen|prolaktin]] (ng/mL) selama 12 bulan dalam terapi hormon feminin pada sampel 20 perempuan trans.<ref>{{Cite journal|last=Gava|first=GiuliaG.|last2=Cerpolini|first2=Silvia|last3=Martelli|first3=Valentina|last4=Battista|first4=Giuseppe|last5=Seracchioli|first5=Renato|last6=Meriggiola|first6=Mariaet Cristinaal.|date=2016|title=Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness|url=https://onlinelibrary.wiley.com/doi/10.1111/cen.13050|journal=Clinical Endocrinology|volume=85|issue=2|pages=239–246|doi=10.1111/cen.13050}}</ref>]]
 
{{TOC limit|3}}
Baris 42:
 
;Sumber tersitasi
* {{cite journal|last=Hembree |first=W. C. |author2=et al. |date=2017|ref={{harvid|Hembree, et al.|2017}}|title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology & Metabolism |volume=102 |issue=11 |pages=3869–3903|doi=10.1210/jc.2017-01658}}
* {{cite book |author=UCSF Transgender Care, Department of Family and Community Medicine, University of California San Francisco |ref={{harvid|USCF Transgender Care|2016}}|title=Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People |editon=2 |editor1-last=Deutsch |editor1-first=M. B. |date=2016 |publisher=UCSF Transgender Care |url=https://transcare.ucsf.edu/guidelines}}
* {{cite book |ref={{harvid|WPATH|2011}} |title=Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People 7th Version |author=World Professional Association for Transgender Health |year=2011 |url=http://www.wpath.org/site_page.cfm?pk_association_webpage_menu=1351&pk_association_webpage=3926 |access-date=2019-07-01 |archive-date=2014-01-28 |archive-url=https://web.archive.org/web/20140128104021/http://www.wpath.org/site_page.cfm?pk_association_webpage_menu=1351&pk_association_webpage=3926 |dead-url=yes }}